Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Net cash provided by operating activities	$ 40,576	$ 554
Cash flows from investing activities:
Sale of investment securities	0	17,792
Purchase of investment securities	0	(1,788)
Proceeds from sale or liquidation of long-term investments	0	8,886
Purchase of long-term investments	(5,000)	0
Investments in non-consolidated real estate businesses	(25)	(1,672)
Distributions from non-consolidated real estate businesses	740	2,165
Proceeds from sale of townhome	0	11,635
Increase in cash surrender value of life insurance policies	(472)	(405)
Decrease in restricted assets	1,286	831
Issuance of notes receivable	(43)	(91)
Proceeds from sale of fixed assets	11	0
Capital expenditures	(2,243)	(2,661)
Net cash (used in) provided by investing activities	(5,746)	34,692
Cash flows from financing activities:
Proceeds from debt issuance	9,870	433
Deferred financing costs	(150)	0
Repayments of debt	(11,526)	(1,444)
Borrowings under revolver	236,595	216,843
Repayments on revolver	(258,064)	(244,076)
Dividends and distributions on common stock	(32,975)	(31,076)
Proceeds from exercise of employee stock options	44	0
Tax benefit of employee stock options exercised	4	665
Net cash (used in) provided by financing activities	(56,202)	(58,655)
Net decrease in cash and cash equivalents	(21,372)	(23,409)
Cash and cash equivalents, beginning of period	240,923	299,825
Cash and cash equivalents, end of period	$ 219,551	$ 276,416